Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 439-840-1 | CAS number: 20846-91-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Carcinogenicity
Administrative data
Description of key information
In good-quality NCI studies, conducted according to a protocol similar to OECD Guideline 451, trisodium ethylenediaminetetraacetate (EDTA) showed no evidence of carcinogenic potential when fed to rats and mice in the diet for 2 years at up to 7500 ppm (about 375 and 1125 mg/kg bw/day, respectively) (NCI, 1977). Based on their structural similarity, it is expected that EDDS acid is also unlikely to induce tumorigenicity following long-term oral exposure at comparable doses.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 375 mg/kg bw/day
Justification for classification or non-classification
According to EU CLP and DSD regulations, EDDS acid would not be classified as carcinogenic based on the data described.
Additional information
No long-term studies assessing the carcinogenic potential of EDDS acid and its simple salts have been identified. However, EDDS acid is not classified as a mutagen (Cat. 3) and there is no evidence from repeated dose studies that the substance is able to induce hyperplasia and/or pre-neoplastic lesions, so such studies are not required under REACH at any tonnage.
In good-quality NCI studies, conducted according to a protocol similar to OECD Guideline 451, trisodium ethylenediaminetetraacetate (EDTA) was assessed for carcinogenic potential in 2-year dietary studies in Fischer 344 rats and B6C3F1 mice. Groups of 50 animals of each sex were fed 3750 or 7500 ppm (approximately 188 or 375 mg/kg bw/day for rats, and 563 and 1125 mg/kg bw/day for mice) for 2 years; groups of 20 control animals of each sex received the untreated diet. Animals were observed twice daily for clinical signs of toxicity and mortalities throughout the study. Body weights were recorded weekly (for the first month) and monthly thereafter. At necropsy all major organs and tissues plus any gross lesions were examined microscopically. In rats, no signs of overt toxicity were observed and body weight gain was similar in both the treated and control groups throughout the study. Survival was similar, or slightly better, in the treated animals than in the controls. In mice, no signs of overt toxicity were observed, but body weight gain was decreased in high-dose males and a small, dose-related decrease was observed in females when compared to the control groups. Survival was similar in all groups. At necropsy, there were no statistically significant differences in the incidence of tumours or non-neoplastic changes between treated animals and their matched controls (NCI, 1977). The final RAR (EU, 2004) also evaluated these studies and concluded that "that there is no concern on carcinogenic properties of EDTA".
A total of 33 Wistar rats (number and sex per group not reported) were divided into 5 groups and dosed with 0, 0.5, 1.0, or 5.0% disodium EDTA in the diet for a period of 2 years (approximately 0, 250, 500, and 2500 mg/kg bw/day, respectively). No gross lesions were observed upon histopathological examination of the internal organs and tissues (which included the heart, liver, pancreas, kidneys, urinary bladder, stomach, small and large intestines, lungs, spleen, ovaries, testes, voluntary muscle, and bone marrow smears). Based on the results of this study, the NOEL was considered to be 2500 mg/kg bw/day disodium EDTA in rats (Yang, 1952). In addition, a NOEL of 250 mg/kg bw/day (the highest tested dose) was seen in Wistar rats (25/sex/group) fed calcium disodium EDTA in the diet for 2 years (Oser et al. 1963).
[Based on its structural similarity with EDTA, and its lack of mutagenic activity, it is expected that EDDS acid is also unlikely to induce neoplasia following long-term oral exposure at comparable doses.]
References (not included elsewhere in IUCLID dossier - need to move to reference list in CSR)
BIBRA (1964). Summaries of toxicological data. Toxicology of EDTA. Food and Cosmetics Toxicology 2, 763-7.
EU (2004). European Union Risk Assessment Report (RAR); edetic acid (EDTA). Vol. 49. European Chemicals Bureau (ECB). Final report available at http://ecb.jrc.ec.europa.eu/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/edtareport061.pdf.
Yang S-S (1952). Toxicological investigation of ethylenediaminetetraacetic acid in the rat. Thesis dated May 1952 (cited in BIBRA, 1964).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
